Monitor the final pricing supplement for the definitive offering size, coupon, and maturity. The proximity to earnings and the stated intent to refinance near-term maturities suggest a liability management exercise rather than new leverage. The EUR 500M 2.425% notes mature December 13, 2026 and the $600M 4.700% notes mature February 19, 2027, creating a refinancing catalyst in the coming months.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 5 $106.85entry
- T+1 · 11d ago −1.18%α −1.49% · $105.59
- T+5 · 5d ago −2.14%α −5.43% · $104.56
- T+7 · todayOpen
- T+20 · in 17d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Zimmer Biomet filed a preliminary 424B5 prospectus supplement for an underwritten offering of euro-denominated senior unsecured notes. The offering size, interest rate, maturity, and pricing are all placeholder TBD values, making this a preliminary filing with no definitive terms. Proceeds are intended for general corporate purposes including potential repayment of EUR 500M 2.425% notes due December 2026 and/or $600M 4.700% notes due February 2027. The filing follows the company's Q3 2026 earnings release on November 4, 2026, which showed modest revenue growth and raised guidance.
Key Financial Metrics
Key Facts
- Preliminary prospectus supplement for an underwritten offering of senior unsecured notes denominated in euro
- Offering size, interest rate, maturity, and pricing are all placeholder values (TBD)
- Proceeds intended for general corporate purposes including potential repayment of EUR 500M 2.425% notes due December 2026 and/or $600M 4.700% notes due February 2027
- Joint book-running managers: Barclays, Citigroup, HSBC, Morgan Stanley, RBC Capital Markets
- Company had approximately $7.5 billion of indebtedness outstanding as of September 30, 2026
- Filed one day after Q3 2026 earnings (8-K on November 4, 2026) which reported net sales of $2.063B (+3.1% reported) and raised full-year guidance
Financial Impact
Undisclosed amount; proceeds will be used for general corporate purposes including potential refinancing of EUR 500M and $600M notes maturing in late 2026 and early 2027
Risk Factors
- Preliminary filing with no definitive terms; actual offering size, pricing, and structure may differ
- Adding new debt increases total leverage and interest expense
- Euro-denominated notes introduce foreign exchange risk for U.S.-based investors
- document contains text addressed to automated readers
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B5 Filing (Primary) | 0001193125-26-448356 |
| Document: 0001193125-26-448356-index-headers.html | 0001193125-26-448356 |
| Document: 0001193125-26-448356-index.html | 0001193125-26-448356 |
| Document: 0001193125-26-448356.txt | 0001193125-26-448356 |
Track record
17 reports on ZBH
3 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +8.74% at T+60 after the Apr 28, 2026 report. 4 of 4 went positive at some point.
Filters
- Nov 12, 20264d ago 8-K Neutral 3/10 Entry $103.21 Now $101.41 −1.74% settles Nov 20
- Nov 9, 20267d ago 424B5 Neutral 3/10 Entry $107.32 Now $101.41 −5.51% settles Nov 17
- Nov 9, 20267d ago 424B5 Neutral 3/10 Entry $107.32 Now $101.41 −5.51% settles Nov 17
- Nov 5, 202611d ago 424B5 Neutral 3/10 Entry $106.85 to $104.56 Now $101.41 −5.09% ▼ −2.14% −5.43% vs SPY
- Nov 5, 202611d ago 424B5 Neutral 2/10 Viewing Entry $106.85 to $104.56 Now $101.41 −5.09% ▼ −2.14% −5.43% vs SPY
- Nov 4, 202612d ago 8-K Neutral 5/10 Entry $110.15 to $107.47 Now $101.41 −7.93% ▼ −2.43% −1.52% vs SPY
- Oct 26, 202621d ago Institutional Cluster Bearish 4/10 Entry $97.44 to $94.52 Now $101.41 −4.07% ▲ +3.00% +1.74% vs SPY
- Oct 21, 202627d ago Court Ruling Bearish 6/10 Entry $98.81 to $97.47 Now $101.41 −2.63% ▲ +1.36% +2.06% vs SPY
- Sep 15, 20268w ago Insider Cluster Neutral 3/10 Entry $96.53 to $90.64 Now $101.41 +5.06% ▼ −6.10% −8.17% vs SPY
- Sep 2, 202610w ago Court Ruling Neutral 2/10 Entry $98.66 to $93.24 Now $101.41 +2.79% ▼ −5.49% −4.34% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers